Poly(amidoamine)

<p>Poly(amidoamine), or PAMAM, is a class of <a href="/facts/Dendrimer/3aXUKBej">dendrimer</a> which is made of repetitively branched subunits of <a href="/facts/Amide/C6kCzYEA">amide</a> and <a href="/facts/Amine/JvfYJfP6">amine</a> <a href="/facts/Functional_group/GXkSPsjM">functionality</a>. PAMAM dendrimers, sometimes referred to by the trade name Starburst, have been extensively studied since their synthesis in 1985, and represent the most well-characterized dendrimer family as well as the first to be commercialized. Like other dendrimers, PAMAMs have a sphere-like shape overall, and are typified by an internal molecular architecture consisting of tree-like branching, with each outward 'layer', or generation, containing exponentially more branching points. This branched architecture distinguishes PAMAMs and other dendrimers from traditional <a href="/facts/Polymer/eF32E50K">polymers</a>, as it allows for low <a href="/facts/Dispersity/8HHtUarc">polydispersity</a> and a high level of structural control during synthesis, and gives rise to a large number of surface sites relative to the total molecular volume. Moreover, PAMAM dendrimers exhibit greater biocompatibility than other dendrimer families, perhaps due to the combination of surface amines and interior amide bonds; these bonding motifs are highly reminiscent of innate biological chemistry and endow PAMAM dendrimers with properties similar to that of <a href="/facts/Globular_protein/PBlAMbBP">globular proteins</a>. The relative ease/low cost of synthesis of PAMAM dendrimers (especially relative to similarly-sized biological molecules such as proteins and antibodies), along with their biocompatibility, structural control, and functionalizability, have made PAMAMs viable candidates for application in drug development, biochemistry, and <a href="/facts/Nanotechnology/Co4FFNfY">nanotechnology</a>.
</p>

Poly(amidoamine) open-in-new

Poly(amidoamine)